Discover how QCH successfully implemented NHF therapy.
Explore how QCH uses NHF therapy across the hospital.
Learn about the research that led to the implementation of NHF therapy at QCH.
The early use of NHF is associated with improved physiological and clinical outcomes compared to standard oxygen therapy, including1-6:
Clinical evidence supports a dose-by-weight approach with suggested flow rates of approximately 2 liters per kilogram per minute (L/kg/min) for infants between 3.0 and 12.5 kilograms.4,7-12
However, there is no evidence to support this practice for preterm neonates, older children or adults. Published clinical protocols may give guidance to setting flow rates in children.7-12 The graphic below summarizes the findings from published literature.
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Noninvasive respiratory support that provides a continuous distending pressure
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment